Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in LIVN — LivaNova PLC

CIK 1164508 BOSTON, MA
Back to LIVN Full portfolio

Position in LIVN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$34,150,941
+$15,823,797 QoQ
Shares Held
415,310
+44.0% QoQ
Ownership
0.754%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 303 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in LIVN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $6,436,102,900 across 46 Medical Devices names. LIVN ranks #14 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 3,282,207 $1,033,370,051
2 MDT
Medtronic plc
 12,892,710 $1,008,596,703
3 BSX
Boston Scientific Corp
 23,293,913 $994,184,206
4 ABT
Abbott Laboratories
 10,897,178 $988,809,931
5 EW
Edwards Lifesciences Corp
 5,677,344 $513,572,538
6 DXCM
Dexcom Inc
 6,873,273 $462,914,936
7 PEN
Penumbra Inc
 834,903 $263,620,622
8 STE
STERIS plc
 1,217,864 $256,445,622

All Filings in LIVN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,150,941 415,310
2026-03-31 $18,327,144 288,344
2025-06-30 $6,114,796 135,824
2025-03-31 $715,799 18,223
2023-03-31 $2,702,134 62,004
2022-12-31 $2,873,250 51,733
2022-09-30 $565,527 11,139
2022-03-31 $5,543,737 67,747
2021-12-31 $15,958,860 182,533
2021-09-30 $23,455,286 296,190
2021-06-30 $26,213,974 311,663
2021-03-31 $660,252 8,955
2020-06-30 $11,591,099 240,829
2020-03-31 $954,775 21,100